Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAR 16 ... with its availability and distribution to the patient base.
Keywords: Azacitidine, Biotechnology Business, Biotechnology Company, Blood Transfusion, Celgene Corporation, ...
2009 MAR 16 ... with its availability and distribution to the patient base.
Keywords: Azacitidine, Biotechnology Business, Biotechnology Company, Blood Transfusion, Celgene Corporation, ...
2009 MAY 18 ... for the development of safer, more-efficacious treatments."
Keywords: Azacitidine, Biotechnology Business, Biotechnology Company, Bone Marrow, Celgene Corporation, ...
2009 JUL 6 ... Floor, Philadelphia, PA 19106-4404, USA. Keywords: United States, Columbus, Azacitidine, Cancer, Cancer Research, DNA, Dacogen, Decitabine, Dietary Supplement, Drug ...
2009 MAR 16 ... of Obstetrics and Gynecology, "The objective of the study was to investigate whether azacitidine sensitizes platinum-resistant ovarian cancer cells to carboplatin and the possible ...
2009 MAR 30 ... core promoter region was not affected by DNA methylation. Primary T cells treated with 5-azacitidine, a DNA methyltransferase inhibitor, showed increased expression of PP2Ac alpha mRNA. We ...
2009 NOV 23 ... a higher risk of AML evolution." "Also, a single patient treated with azacitidine, a DNA methyltransferase inhibitor currently used in MDS, displayed a direct correlation ...
2009 JUN 29 ... myeloid leukemia are presented in the report 'The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute ...
2009 MAY 4 ... syndromes provide no survival advantage. In this trial, we aimed to assess the effect of azacitidine on overall survival compared with the three commonest conventional care regimens," ...
2009 AUG 3 ... "Two nucleoside inhibitors of DNA methylation, azacitidine and decitabine, are now standard of care for the treatment of the myelodysplastic ...
2009 JUN 22 ... Revlimid® (lenalidomide) and a planned phase II clinical trial combined with Vidaza® (azacitidine). Lintuzumab Phase I Single-Agent Study Data from 82 patients treated in the ...
2009 NOV 23 ... in In Vitro Combination with Cytarabine and Additive in Combination with Azacitidine, Decitabine and Clofarabine Keywords: Sunesis Pharmaceuticals, Inc., ...
2009 AUG 18 ... The updated recommendations state VIDAZA, also known by its chemical name azacitidine, "should be considered for treating MDS patients with progressing or relatively ...
2009 AUG 17 ... The updated recommendations state VIDAZA, also known by its chemical name azacitidine, "should be considered for treating MDS patients with progressing or relatively ...
